DEPO Depomed 4.3

Depomed, Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products based on its proprietary oral drug delivery technologies in the United States. The company’s product line comprises GLUMETZA for the treatment of type ii diabetes; ProQuin XR for uncomplicated urinary tract infection; Gabapentin GR is in second phase third study for postherpetic neuralgia, diabetic peripheral neuropathy, and menopausal hot flashes; and Omeprazole for gastroesophageal reflux disease. It also develops other product candidates for treatment of gastroesophageal reflux disease are in preclinical studies stage. The company sells its products trough wholesalers and retail pharmacies. The company has a collaboration agreement with Supernus Pharmaceuticals, Inc. to develop a product candidate leveraging its AcuForm drug delivery technology; and Patheon, Inc. Depomed, Inc. was founded in 1995 and is headquartered in Menlo Park, California.

Advertisements
This entry was posted in doji, Uncategorized and tagged . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s